Health Condition 1: M47- Spondylosis Health Condition 2: M45-M49- Spondylopathies
Conditions
Interventions
Intervention1: Spondygen p50: it is the combination of Sameerpannag Ras and Mahavat-Vidhvansan ras and Ekangavir Ras and Trikatu extract and Palash Extract and Vacha Extract
Control Intervention1: NA:
Sponsors
Sudhatatva Pharmacy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients suffering from spondylosis from the age group of 30–70 years of either sex were selected 2. History of Spondylosis less than 5 years. 3. Patient willingly ready for informed consent
Exclusion criteria
Exclusion criteria: 1. The patients who had history of uncontrolled diabetes and uncontrolled systemic arterial hypertension, severe anemia with serum hemoglobin level less than 6 percent. 2. Individuals with any congenital deformity related to spine. 3. Individuals with known allergies to ingredients of interventional drug. 4. Pregnant or breastfeeding women. 5. Recent participation in another clinical trial
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Enhance quality of life with better safety and tolaribilityTimepoint: 28 days | — |
Primary
| Measure | Time frame |
|---|---|
| Anticipated outcome for the pilot exploratory clinical trial of spondygen p50 in spondylosis is that will significantly reduce the pain and ease the daily activity.Timepoint: 28 days | — |
Countries
India
Contacts
Public ContactNilima Dharkar
Dr D Y Patil college of Ayurved and Research centre Pimpri Pune
Outcome results
None listed